- Filed
- Apr 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 15, 2025 | 13.61M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $1.41K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $49.15K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $871.23K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $976.89K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.87M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.98M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $9.49K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $56.52K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $19.5K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $89.14K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 10.36M sh |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$307.65K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$1.44M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$1.25M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $150.43K |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$240.35K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$221.79K |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $80.53K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $125.83K |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $206.36K |